Product Information
DESIPRAMINE 75 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.2757 per EA under NDC 69238105901. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Mar 17, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238105901
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DESIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208105FDA Approved
3/17/2016
TE Code
AB
On Market Since
3/21/2016
Pharmacological Classes
Price Statistics
The NADAC for DESIPRAMINE 75 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 41.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2757 per EA |
|---|---|
| All-time high | $0.4773 (Jul 10, 2024) |
| All-time low | $0.2711 (Nov 20, 2024) |
| 52-week high | $0.3512 |
| 52-week low | $0.2757 |
| Median price | $0.3224 |
| Average price | $0.3385 |
| Largest weekly change | -27.6% (Sep 18, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Desipramine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Desipramine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESIPRAMINE 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DESIPRAMINE 75 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $0.2757 per EA (NDC 69238105901), effective Sep 30, 2026.
How has the price of DESIPRAMINE 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for DESIPRAMINE 75 MG TABLET has declined 41.5%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DESIPRAMINE 75 MG TABLET?
Since Apr 17, 2024, the NADAC for DESIPRAMINE 75 MG TABLET has ranged from a low of $0.2711 (Nov 20, 2024) to a high of $0.4773 (Jul 10, 2024), with a median of $0.3224 per EA.
Are there cheaper alternatives to DESIPRAMINE 75 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DESIPRAMINE 75 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DESIPRAMINE 75 MG TABLET?
DESIPRAMINE 75 MG TABLET (NDC 69238105901) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.